1. Home
  2. XLO vs MATH Comparison

XLO vs MATH Comparison

Compare XLO & MATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

XLO

Xilio Therapeutics Inc.

HOLD

Current Price

$9.15

Market Cap

56.9M

Sector

Health Care

ML Signal

HOLD

MATH

Metalpha Technology Holding Limited

HOLD

Current Price

$0.94

Market Cap

39.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
XLO
MATH
Founded
2016
2015
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
56.9M
39.7M
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
XLO
MATH
Price
$9.15
$0.94
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$28.00
N/A
AVG Volume (30 Days)
41.9K
23.3K
Earning Date
05-14-2026
05-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$43,766,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$168.77
N/A
P/E Ratio
N/A
$3.10
Revenue Growth
589.88
N/A
52 Week Low
$0.46
$0.80
52 Week High
$9.89
$4.10

Technical Indicators

Market Signals
Indicator
XLO
MATH
Relative Strength Index (RSI) 55.21 50.42
Support Level $7.47 $0.88
Resistance Level $9.89 $1.04
Average True Range (ATR) 0.39 0.08
MACD -0.04 -0.00
Stochastic Oscillator 76.24 63.64

Price Performance

Historical Comparison
XLO
MATH

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.

About MATH Metalpha Technology Holding Limited

Metalpha Technology Holding Ltd is a digital asset focused wealth management company. The company predominantly generates revenue from the execution of cryptocurrency-related transactions, which includes the issuance of derivative products to over-the-counter (OTC) clients and its proprietary trading activities. It has partnered with a crypto exchange to provide crypto derivative market-making services for its clients, facilitating the trading of crypto derivative products. In addition, the company also engages in providing traditional financial derivative products, and asset management services. It operates in a single segment which is the trading of proprietary digital assets and derivative contracts, and generates majority of its revenue from Hong Kong.

Share on Social Networks: